Sucrose

Sucrose

SCHEMBL285512

CCCCCCCCCCCCCCCCCC(=O)O.OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Sucrose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.59
CCNB1 P14635 1/20 0.59
SELL P14151 3/20 0.44
SELP P16109 3/20 0.44
SELE P16581 3/20 0.44
PTPN1 P18031 1/20 0.43
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LDHA P00338 1/20 0.41
MAPK1 P28482 1/20 0.40
GJB2 P29033 1/20 0.40
EPHX2 P34913 1/20 0.39
TLR4 O00206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sucrose SCHEMBL16859920 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL949885 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL5030245 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL18141748 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL21121139 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL1067854 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL3947585 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL1878330 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL1874820 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE
Sucrose SCHEMBL285432 1.00 CDK1 (0.59) CDK1CCNB1SELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3732993-B1 LYCOPENE COLORANT HAVING FRESH-KEEPING FUNCTION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CHENGUANG BIOTECH GROUP CO LTD (CN) 2025-03-12 EP claimed
EP-3310439-B1 PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS COMPRISING BENZODIAZEPINE AND KETAMINE MELT PHARMACEUTICALS INC (US) 2024-05-29 EP claimed
EP-3220893-B1 COMPOSITION BASED ON COQ10 ASOLTECH SRL (IT) 2023-06-07 EP claimed
EP-4694687-A1 A METHOD FOR PRESERVING OR ENHANCING YIELD OF A FIELD-CULTIVATED CROP EXPOSED TO AT LEAST ONE ABIOTIC STRESS Elicit Plant (FR) 2026-02-18 EP disclosed
EP-3227345-B1 METHOD FOR PRODUCING WATER-ABSORBING POLYMER PARTICLES BY SUSPENSION POLYMERIZATION BASF SE (DE) 2026-01-07 EP disclosed
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 US disclosed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP disclosed
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. 2025-05-15 US disclosed
US-20250154167-A1 METHOD OF TREATMENT OF SYMPTOMS OF MENOPAUSE KaNDy Therapeutics Limited (GB) 2025-05-15 US disclosed
CN-119950513-A Novel pharmaceutical formulations containing dual NK-1/NK-3 receptor antagonists KaNDy治疗有限公司 2025-05-09 CN disclosed
US-20250127694-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. 2025-04-24 US disclosed
CN-103525602-B Soap lye SHANGHAI SOAPMAKING CO., LTD. (CN) 2015-12-02 CN disclosed
CN-104605118-A Honey soft sweets and preparation method thereof PENG JUN 2015-05-13 CN disclosed
CN-103533947-A Plant extracts for the treatment and prevention of infections KAMEDIS LTD 2014-01-22 CN disclosed
CN-103525602-A Soap solution SHANGHAI SOAP CO LTD 2014-01-22 CN disclosed
US-20130323335-A1 PLANT EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFECTIONS BIO-FD&C CO. LTD. (KR) 2013-12-05 US disclosed
EP-2428200-A2 Novel compositions Malvern Cosmeceutics Limited (GB) 2012-03-14 EP disclosed
US-20100062067-A1 COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT MALVERN COSMECEUTICS LIMITED (GB) 2010-03-11 US disclosed
EP-2099410-A2 COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT Malvern Cosmeceutics Limited (GB) 2009-09-16 EP disclosed
WO-2008065451-A2 COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT MALVERN COSMECEUTICS LIMITED (GB) 2008-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250127694-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF TRPA1, TRPV1, NAA40 CDK1 3873/4885CCNB1 4448/4885SELL 4372/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 CDK1 3208/4885CCNB1 4129/4885SELL 648/4885
US-20100062067-A1 COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT CLTB, APOB, ABCB4 CDK1 4854/4885CCNB1 2235/4885SELL 1972/4885
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF FHIT, ALG3, FEM1B CDK1 4776/4885CCNB1 4327/4885SELL 3872/4885
US-20250154167-A1 METHOD OF TREATMENT OF SYMPTOMS OF MENOPAUSE CYP19A1, MTNR1B, SHBG CDK1 1589/4885CCNB1 1392/4885SELL 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.